awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q24681480-F502F680-904C-42F4-9B97-EDBD9EE8E643
Q24681480-F502F680-904C-42F4-9B97-EDBD9EE8E643
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24681480-F502F680-904C-42F4-9B97-EDBD9EE8E643
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
P2860
Q24681480-F502F680-904C-42F4-9B97-EDBD9EE8E643
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24681480-F502F680-904C-42F4-9B97-EDBD9EE8E643
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bd773e325c1692a3e0ff309c95a6506fcef953e0
P2860
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer.